MYX 3.29% $4.40 mayne pharma group limited

Mithra has already stated that manufacturing operations is under...

  1. 138 Posts.
    lightbulb Created with Sketch. 33
    Mithra has already stated that manufacturing operations is under strategic review since the new ceo was appointed. we may hear soon about the outcome. CMO business is a hot cake in Europe and US so be surprised this get picked up pretty quick by one of multinationals

    they probably want to see some increased levels of activity for nextellis which should translate in higher multiple for manufacturing sale
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.